Aspira Women's Health Employee Directory

Biotechnology ResearchConnecticut, United States51-200 Employees

Aspira Women’s Health is a biotechnology research company focused on gynecologic health diagnostics, headquartered in Trumbull, Connecticut, and employing 51–200 people. It develops and markets ovarian cancer risk assessment tools under the OvaSuite portfolio, including OvaWatch, a non-invasive blood test used for initial risk assessment in women with benign or indeterminate adnexal masses. OvaWatch has a reported negative predictive value of 99%, enabling clinicians to rule out ovarian malignancy and guide patient management. The Ova1Plus offering combines FDA-cleared Ova1 and Overa tests to assess the risk of malignancy in women with adnexal masses planned for surgery. The company is pursuing a non-invasive diagnostic for endometriosis, EndoCheck, which is currently in development, and reports revenue in the range of $25–50 million.

Sign up for free to view info

Company overview Email format